ReviewTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2014

PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatments for patients with metastatic castration-resistant prostate cancer: an analysis of 22 trials.

Edoardo Francini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.